24.08.2022 • NewsWuXi STAPharmaceuticalpackaging

WuXi STA Breaks Ground on US Pharma Campus

Chinese contract research, development and manufacturing organization WuXi STA, a subsidiary of WuXi AppTec, has broken ground on a new pharmaceutical campus in Middletown, Delaware, USA.

First announced in June 2021, the site will be WuXi STA’s second facility in the US, providing expanded capacity and greater flexibility to meet the needs of customers both in the US and worldwide.

The facility is expected to start operating in 2025 and will create roughly 500 full-time jobs by 2026. The first phase will provide formulation development, clinical and commercial drug product manufacturing services for a variety of oral and injectable dosage forms, as well as packaging, labeling, storage and distribution services for clinical trial materials and commercial drug products.

WuXi STA has 12 sites across the US, Europe and Asia that offer a range of services, as well as three other drug product manufacturing sites in Couvet, Switzerland, and Wuxi City and Shanghai in China.

Last month, the company opened a new continuous manufacturing plant for large-scale API and advanced intermediate production, as well as a large-scale oligonucleotide and peptide manufacturing facility at its Changzhou campus in China.

In addition, WuXi AppTec announced plans on Jul. 19 to invest up to $1.43 billion in a new R&D and manufacturing site in Singapore. The investment is expected to be made in stages over the next 10 years, depending on the company’s business needs.

Author: Elaine Burridge, Freelance Journalist

© WuXi STA
© WuXi STA

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.